Raymond James initiated coverage of Rocket Lab (RKLB) with an 'Outperform' rating and an $80 price target, citing significant upside potential from its Neutron rocket and the Iridium/Mynaric expansion. The firm highlighted Rocket Lab's strong revenue and backlog growth, with a potential path to positive adjusted EBITDA and free cash flow by 2027-2028. Rocket Lab is nearing its 100th Electron mission and is expanding its capabilities beyond rocket launches into an end-to-end space company.

Stephens has increased its price target for Darden Restaurants (NYSE:DRI) to $220.00 from $216.00, maintaining an "equal weight" rating and suggesting a 5.87% upside. The company's stock currently holds a "Moderate Buy" consensus rating with an average target of $230.67 from analysts. Darden recently reported strong quarterly results, beating EPS estimates and showing a 13.7% revenue increase year-over-year, while also providing positive fiscal 2027 EPS guidance.

KeyCorp initiated coverage on Huntsman (NYSE:HUN) with an "overweight" rating and a $14 price target, suggesting a 47% upside. This new rating comes amidst mixed analyst sentiment, with the stock currently holding a consensus "Hold" rating from 14 analysts, with an average price target of $12.62. The article also highlights recent insider buying by CEO Peter R. Huntsman and significant institutional investment, including a large increase by the California State Teachers' Retirement System.

T-Mobile US Inc.'s CFO, Pete Osvaldik, asserted that Elon Musk's Starlink is not a competitive threat to traditional wireless carriers due to fundamental physics limitations regarding signal strength and indoor coverage. While acknowledging Starlink's potential in rural broadband, he questioned SpaceX's management strategy for its network. This comes as SpaceX plans to expand Starlink Mobile services and has secured a significant AI compute deal.

Stephens has increased its price target for Darden Restaurants (NYSE:DRI) to $220 from $216, maintaining an Equal Weight rating, expecting the company to surpass Q1 fiscal 2027 earnings consensus. The firm anticipates strong performance from Olive Garden and LongHorn, driven by value marketing and the value steakhouse segment. Despite current market overvaluation, Darden's financial strength, consistent dividend increases, and ability to sustain traffic and market share gains are key investor focuses.

Allarity Therapeutics has announced that its newly formed special purpose acquisition company, Allarity Acquisition Corp., filed a Registration Statement for a proposed initial public offering of $100 million, potentially increasing to $115 million. A subsidiary of Allarity Therapeutics will serve as the sponsor, and the SPAC aims to list its units on Nasdaq under the symbol ALLNU. The offering does not affect Allarity Therapeutics' previously stated financial stability until summer 2028.

Cantor Fitzgerald has reiterated its Neutral rating on Humana Inc. (NYSE:HUM) stock, setting a $300.00 price target despite the stock currently trading significantly higher at $400.73 after a 136% surge. The firm expressed optimism regarding Humana's 2027 Stars ratings, noting that the company's investments in its Stars program are likely sufficient and that concerns about UnitedHealth Group related to CAHPS are misplaced. This positive outlook on Medicare Advantage margin and pricing cycle is supported by lighter-than-expected movement in cutpoints.

Cantor Fitzgerald has reiterated an Overweight rating and $75.00 price target for Centene (NYSE:CNC), citing optimism regarding the early October 2026 release of 2027 Stars ratings. The firm noted that fewer 4-Star thresholds became more difficult in 2027 compared to 2026, suggesting that Humana's Stars program investments could be sufficient. This analysis, which also covered other managed care companies, further supports the Medicare Advantage margin and pricing cycle.

Piper Sandler has initiated coverage on WEX Inc. (NYSE:WEX) with a Neutral rating and a price target of $209.00, suggesting a 10% upside from its current trading price of $190.03. The firm sees potential for EPS growth through WEX's Benefits and Corporate Payments segments, although concerns exist regarding Mobility business cyclicality, credit and funding exposure, and leverage. WEX recently surpassed Q2 2026 earnings and revenue expectations, leading Cantor Fitzgerald to raise its price target to $178 while maintaining a Neutral rating.

This article compiles recent analyst rating changes and price target adjustments for ten different companies, including ServiceNow, Darden Restaurants, McDonald's, and Robinhood Markets. Needham raised ServiceNow's price target to $155, suggesting an 18% rally from its previous closing price. The report also highlights downgrades for McDonald's and Wingstop, alongside upgrades for Robinhood and Workiva.